Aurobindo Pharma is revisiting plans to sell a strategic stake in its injectable unit, Eugia Pharma Specialities, focusing on an IPO. Previ...

US-based Zeda Holdings plans to raise $200 million for its India expansion, led by CEO Shri Shetty. The company uses 3D printing for orthop...

The USFDA approval paves the way for Glenmark's subsidiary Glenmark Specialty to proceed with a Phase 1/2, first-in-human, clinical study o...

The Indian drug makers are finally seeing a recovery with most of their factories being cleared by the US watchdog.

Scott Gottlieb is known to favour quicker entry of generic drugs in the market.

While the broad-based Nifty Pharma index is down 12.4% from November 4 till date, the loss has been more pronounced in individual stocks.

The warning letter issued by the US Food and Drug Administration will impact Dr Reddy's new drug approvals, the company said.

Cipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and y...

This is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in March this year to create the world's fifth...

An Indian subsidiary of Apotex manipulated laboratory data, retesting samples until the results were acceptable, according to a warning let...

India has called for a review of the US whistleblower policy as it feels generous incentives offered by USFDA may lead to policy abuse by s...

The US drug regulator has in 2013 hauled up leading India-based firms like Ranbaxy for failure to comply with good manufacturing practices.

USFDA plans to conduct workshops across India in the next one year in order to sanitise Indian drug cos about the changing quality requirem...

India's drug regulator may urge USFDA chief to ensure that drugmakers from US conducting clinical trials treat the volunteers on internatio...

Ranbaxy Laboratories has set aside Rs 257.4 crore towards the financial impact of a US ban on import of products made at its plant at Toans...

Strides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Pol...

Ranbaxy is in talks with the US Food and Drug Administration (USFDA)to sort out issues related to generic drugs but the matter is likely to...